Results 141 to 150 of about 7,177,989 (337)
ABSTRACT Background Basaloid Squamous cell carcinoma (BSCC) is a rare subtype of squamous cell carcinoma whose cytomorphologic features on lung fine needle aspiration (FNAB) can mimic small cell lung carcinoma (SCLC), creating a diagnostic dilemma. As the distinction is critical for patient management and prognosis, this study aimed to determine if ...
J. Egan +3 more
wiley +1 more source
ESOPHAGEAL SQUAMOUS CELL CARCINOMA
The esophageal cancer is one of the fatal malignancies around the world, with a dramatic increase in incidence rates in the Western world occurring over the past few decades. Esophageal cancer is the 8th most common cancer and the 6th most common cause of cancer deaths worldwide despite improvements in the management and the therapeutic approach.
openaire +3 more sources
A Cuproptosis Nanoparticle Reverses Lung Adenocarcinoma Drug Resistance
Copper‐based nanoparticles offer a promising strategy to improve treatment for KRAS‐mutated lung adenocarcinoma. These nanoparticles release copper ions in acidic environments, triggering copper‐dependent cell death and reducing ATP7B expression.
Leilei Wu +11 more
wiley +1 more source
What's New? This study introduces a novel approach for detecting locally advanced esophageal carcinoma using cell‐free DNA (cfDNA) analysis through a highly sensitive fragmentome assay. Unlike traditional sequencing‐based methods that are limited by the absence of specific mutations in esophageal tumors, our method offers an alternative by quantifying ...
Anouchka Modesto +21 more
wiley +1 more source
Epidemiology of esophageal and hypopharyngeal squamous cell carcinoma
The incidence of esophageal squamous cell carcinoma (SCC) exceeds that of esophageal adenocarcinoma (AC) in all developing countries and in most developed countries, including Italy. By contrast, the incidence of AC has recently approached that of SCC in
DE MANZONI, Giovanni, VERLATO, Giuseppe
core +1 more source
The purpose of the study was to investigate rare cases of concurrent incidence of esophageal squamous cell carcinoma and gastric adenocarcinoma to develop an effective treatment strategy.Material and Methods. Herein, we present a report of three cases of
E. A. Toneev +7 more
doaj +1 more source
ABSTRACT Adjuvant nivolumab is approved for esophageal or gastroesophageal junction cancer after neoadjuvant chemoradiotherapy and resection. In the CheckMate‐577 trial, Grade 3–5 nivolumab‐related adverse events (AEs) occurred in 5% of patients, with early discontinuation due to toxicity in 9%. However, real‐world data on immunotherapy‐related adverse
Michelle Koops van ’t Jagt +7 more
wiley +1 more source
Background: In recent studies, microRNAs have been demonstrated as stable detectable biomarkers in blood for cancer. In addition, computer-aided biomarker discovery has now become an attractive paradigm for precision diagnosis. Methods: In this study, we
Yonghong Wang MM +5 more
doaj +1 more source
12-0-Tetradecanoyl phorbol-13-acetate induced differentiation in human lung squamous carcinoma cells. [PDF]
Three human lung squamous carcinoma cell lines (NX002, CX140 and CX143) demonstrate features of squamous differentiation including involucrin synthesis and competence to form cornified envelopes.
?, ?
core +1 more source
ABSTRACT Long‐term survival data for patients with locally advanced gastro‐esophageal adenocarcinoma (GEA) treated with neoadjuvant chemoimmunotherapy are lacking. We describe the long‐term disease‐free survival (DFS) and overall survival (OS) outcomes of such patients treated with a novel neoadjuvant chemoimmunotherapy regimen, aDCF (avelumab with ...
Thierry Alcindor +8 more
wiley +1 more source

